Vanguard Personalized Indexing Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,644	Closed	-$18.5K	–	1777
2024 Q1	$18.5K	Buy	+11,644	New	+$17.3K	﹤0.01%	1606

Vanguard Personalized Indexing Management's NGM Position: Q2 2024 in Review

Vanguard Personalized Indexing Management sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 11,644 shares — an estimated $18.5K sold.

Vanguard Personalized Indexing Management first reported a position in NGM in Q1 2024 and held it in 1 quarter. The position peaked at $18.5K in Q1 2024. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

Vanguard Personalized Indexing Management reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Vanguard Personalized Indexing Management sold 11,644 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $18.5K.
Vanguard Personalized Indexing Management first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Vanguard Personalized Indexing Management's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $18.5K in Q1 2024.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2024, filed 12 Aug 2024.